Literature DB >> 16531707

[Identification of cancer stem cells in the "side population"].

Tetsuya Taga1.   

Abstract

Both normal somatic stem cells and cancer cells are thought to be capable of unlimited proliferation. Paradoxically, however, some cancers seem to contain stem-like cells (cancer stem cells). There is increasing evidence that cancers might contain their own stem cells. Many cancers, like normal organs, seem to be maintained by a hierarchical organization that includes slowly dividing stem cells,rapidly dividing transit amplifying cells (precursor cells), and differentiated cells. Malignant gliomas, for example,often contain both undifferentiated and differentiated cells and sometimes contain cells that express neuronal markers as well as cells that express glial markers, suggesting that they may contain multipotent neural stem cell-like cells. We have shown that some cancer cell lines contain a small side population (SP), which, in many normal tissues, is thought to contain the stem cells of the tissue. We provide evidence that SP cells in the C6 glioma cell line can produce both neurons and glial cells and thus have cancer stem cell property. Taken together with studies on normal neural stem cells, studies on cancer stem cells will help us to understand a link between normal stem cells and cancer stem cells.

Entities:  

Mesh:

Year:  2006        PMID: 16531707

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Persistence of side population cells with high drug efflux capacity in pancreatic cancer.

Authors:  Jing Zhou; Chun-You Wang; Tao Liu; Bin Wu; Feng Zhou; Jiong-Xin Xiong; He-Shui Wu; Jing Tao; Gang Zhao; Ming Yang; Shan-Miao Gou
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

2.  Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.

Authors:  Zheng-Yuan Xie; Mao-Sheng Liu; Cong Zhang; Peng-Cheng Cai; Zhi-Hua Xiao; Fen-Fen Wang
Journal:  Biosci Rep       Date:  2018-11-09       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.